Idiopathic interstitial pneumonia: peculiarities of clinical picture and treatment


Citar

Texto integral

Resumo

Idiopathic interstitial pneumonias (IIP) combine several diseases from the group of interstitial lung disease characterized by many similar signs: unknown etiology, progressive exertional breathlessness, diffuse lesions on the lung X-ray and CT, and restrictive ventilatory insufficiency. However, these diseases have a sufficient number of differences (primarily morphological; approach to therapy and prognosis), to consider each of the forms of IIP as separate nosological entity. Modern ATS/ERS classification includes seven forms of IIP, the most common of which are discussed in this article.

Sobre autores

S Avdeev

S Avdeev

Bibliografia

  1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
  2. American Thoracic Society. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. International Consensus Statement. Am J Respir Crit Care Med 2000;161:646-64.
  3. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-16.
  4. Baumgartner KB, Samet J, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-48.
  5. Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 2000;152:307-15.
  6. Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804-08.
  7. British Thoracic Society recommendations. The diagnosis, assessment and treatment of diffuse parenchymal disease in adults. Thorax 1999;54(Suppl.1):S1-S30.
  8. Johnston IDA, Prescott RJ, Chalmers JC, et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997;52:38-44.
  9. Alhamad EH, Lynch JP, Martinez FJ. Pulmonary function in interstitial lung disease: what role do they have? Clin Chest Med 2001:715-50.
  10. Pipavath S, Godwin JD. Imaging of interstitial lung disease. Radiol Clin N Am 2005;43:589-99.
  11. Corrin B. Pathology of interstitial lung diseases. Semin Resp Crit Care Med 1994;15:61-76.
  12. Daniels CE, Ryu JH. Treatment of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med 2006;27:668-76.
  13. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-47.
  14. King TE, Behr J, Brown KK, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177:75-81.
  15. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42.
  16. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
  17. Flaherty KR, Martinez FJ. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med 2006;27:652-58.
  18. Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-93.
  19. Shimizu S, Yoshinouchi T, Ohtsuki Y, et al. The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia. Respir Med 2002;96:770-76.
  20. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
  21. Watanabe K, Higuchi K, Ninomiya K, et al. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 2002;20:1213-19.
  22. Drent M, du Bois RM, Poletti V. Recent advances in the diagnosis and management of nonspecific interstitial pneumonia. Curr Opin Pulm Med 2003;9:411-17.
  23. Davison AG, Heard BE, McAllister WAC, et al. Cryptogenic organizing pneumonitis. Q J Med 1983;52:382-94.
  24. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-58.
  25. Muller N, Muller R. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995;196:3-12.
  26. Cordier J-F. Cryptogenic organising pneumonia. Eur Respir J 2006;28:422-46.
  27. Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med 2000;162:571-77.
  28. Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010-19.
  29. Cohen AJ, King TE, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149:1670-75.
  30. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965;39:369-404.
  31. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
  32. Carrington CB, Gaensler EA, Coutu RE, et al. Usual and desquamative interstitial pneumonia. Chest 1976;69:261-63.
  33. Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005;127:178-84.
  34. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787-90.
  35. Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climat Assoc 1935;51:154-63.
  36. Askin FB. Back to the future: The Hamman-Rich syndrome and acute interstitial pneumonia. Mayo Clin Proc 1990;65:1624-26.
  37. Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65:1538-48.
  38. Bouros D, Nicholson AC, Polychronopoulos V, et al. Acute interstitial pneumonia. Eur Respir J 2000;15:412-18.
  39. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10:256-67.
  40. Vourlekis JS, Brown KK, Cool CD, et al. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) 2000;79:369-78.
  41. Ichikado K, Johkoh T, Ikezoe J, et al. Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. Am J Roentgenol 1997;168:333-38.
  42. Johkoh T, Muller NL, Taniguchi H, et al. Acute interstitial pneumonia: Thin-section CT findings in 36 patients. Radiology 1999;211:859-63.
  43. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2462&mid=1085056570&magid=183

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2009

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies